论文部分内容阅读
目的:探讨舒利迭联合无创通气治疗老年慢性阻塞性肺疾病呼吸衰竭的临床效果。方法:接收在我院老年慢性阻塞性肺疾病伴有呼吸衰竭的患者一共有74例,随机分为治疗组、对照组,对照组采取常规治疗,治疗组在此基础之上采取舒利迭联合无创通气治疗,对比两组病人的治疗效果。结果:治疗前,两组病人的RR和HR评分之间的差异不具有统计学意义(P>0.05);治疗后,治疗组病人的RR和HR评分明显低于对照组,其之间的差异具有统计学意义(P<0.05);治疗前,两组病人的血气各项观察指标评分之间的差异不具有统计学意义(P>0.05);治疗后,治疗组病人的血气各项观察指标改善情况明显优于对照组,其之间的差异具有统计学意义(P<0.05)。结论:对老年慢性阻塞性肺疾病呼吸衰竭采取舒利迭联合无创通气共同治疗,可以使血气以及肺功能指标得到明显改善,临床疗效可靠,具有较高的临床应用价值。
Objective: To investigate the clinical effect of seretide combined with noninvasive ventilation in treatment of respiratory failure in elderly patients with chronic obstructive pulmonary disease. Methods: A total of 74 patients with chronic obstructive pulmonary disease and respiratory failure in our hospital were randomly divided into treatment group, control group and control group. The treatment group took the combination of seretide Non-invasive ventilation treatment, the treatment of patients compared two groups. Results: Before treatment, there was no significant difference between the two groups in RR and HR scores (P> 0.05). After treatment, the RR and HR scores in the treatment group were significantly lower than those in the control group (P <0.05). Before treatment, there was no significant difference between the two groups in the observation scores of blood gas (P> 0.05). After treatment, all the observed indexes of blood gas in the treatment group The improvement was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion: The combination of seretide and noninvasive ventilation in elderly patients with chronic obstructive pulmonary disease respiratory failure can significantly improve the blood gas and pulmonary function indexes, and has reliable clinical effect and high clinical value.